Daré Bioscience (DARE) Institutional Ownership $3.34 +0.01 (+0.30%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Daré Bioscience (NASDAQ:DARE)CurrentInstitutional OwnershipPercentage6.70%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$63.72KNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$3.81M Get DARE Insider Trade Alerts Want to know when executives and insiders are buying or selling Daré Bioscience stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data DARE Institutional Buying and Selling by Quarter Daré Bioscience Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/16/2024Geode Capital Management LLC89,060$289K0.0%-91.2%1.042% 11/15/2024State Street Corp23,515$76K0.0%-91.7%0.275% 8/9/2024Renaissance Technologies LLC778,700$262K0.0%+2.1%9.247% 11/15/2023Armistice Capital LLC6,470,000$2.99M0.0%N/A7.370% 5/1/2023Virtu Financial LLC32,481$34K0.0%-58.1%0.038% 2/8/2023Founders Financial Securities LLC114,000$95K0.0%-67.2%0.134% 11/7/2022Virtu Financial LLC68,242$68K0.0%+29.2%0.080% 10/27/2022Founders Financial Securities LLC347,824$5.27M0.9%+236.1%0.410% 7/27/2022Founders Financial Securities LLC103,500$127K0.0%N/A0.122% 7/19/2022Commonwealth Equity Services LLC43,579$53K0.0%+57.8%0.051% Get the Latest News and Ratings for DARE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Daré Bioscience and its competitors with MarketBeat's FREE daily newsletter. 5/11/2022GSA Capital Partners LLP125,954$188K0.0%-11.2%0.150% 5/10/2022Buckingham Strategic Partners30,000$45K0.0%+200.0%0.036% 2/14/2022GSA Capital Partners LLP141,843$284K0.0%+1,077.5%0.185% 2/8/2022Raymond James Financial Services Advisors Inc.30,000$60K0.0%N/A0.039% 11/15/2021HighTower Advisors LLC22,035$36K0.0%-26.6%0.031% 11/12/2021Renaissance Technologies LLC324,030$541K0.0%+346.4%0.459% 11/10/2021Goldman Sachs Group Inc.255,282$426K0.0%+1,349.9%0.362% 11/9/2021BlackRock Inc.122,725$205K0.0%-9.0%0.174% 10/19/2021Interwest Venture Management Co.62,065$104K0.0%+23.2%0.088% 10/15/2021 Paradigm Strategies in Wealth Management LLC23,105$39K0.0%+131.1%0.033% 8/16/2021State Street Corp62,630$118K0.0%N/A0.127% 8/13/2021Renaissance Technologies LLC72,590$137K0.0%-91.7%0.147% 8/13/2021Geode Capital Management LLC310,318$586K0.0%+19.7%0.629% 8/13/2021Vanguard Group Inc.1,941,258$3.67M0.0%+37.2%3.934% 8/12/2021XTX Topco Ltd14,101$27K0.0%N/A0.029% 8/11/2021Commonwealth Equity Services LLC25,875$48K0.0%+55.6%0.052% 8/6/2021HighTower Advisors LLC30,035$57K0.0%+87.3%0.061% 5/19/2021Virtu Financial LLC149,593$253K0.0%+549.5%0.303% 5/19/2021Squarepoint Ops LLC142,133$240K0.0%N/A0.288% 5/17/2021Goldman Sachs Group Inc.24,555$41K0.0%-78.8%0.052% 5/13/2021Renaissance Technologies LLC872,408$1.47M0.0%+23.3%1.844% 5/12/2021Geode Capital Management LLC259,243$438K0.0%+22.8%0.548% 5/12/2021CIBC Private Wealth Group LLC25,000$42K0.0%N/A0.053% 5/10/2021HighTower Advisors LLC16,035$27K0.0%-49.9%0.034% 5/4/2021Commonwealth Equity Services LLC16,625$28K0.0%N/A0.035% 2/10/2021HighTower Advisors LLC32,034$42K0.0%+33.3%0.077% 2/4/2021GSA Capital Partners LLP144,323$193K0.0%N/A0.347% (Data available from 1/1/2016 forward) DARE Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of DARE shares? During the previous two years, the following institutional investors and hedge funds held shares of Daré Bioscience shares: Armistice Capital LLC ($2.99M), Geode Capital Management LLC ($289K), Renaissance Technologies LLC ($262K), Founders Financial Securities LLC ($95K), and State Street Corp ($76K), Virtu Financial LLC ($34K).Learn more on DARE's institutional investors. What percentage of Daré Bioscience stock is owned by institutional investors? 6.70% of Daré Bioscience stock is owned by institutional investors. Learn more on DARE's institutional investor holdings. Which institutional investors have been buying Daré Bioscience stock? The following institutional investors have purchased Daré Bioscience stock in the last 24 months: Armistice Capital LLC ($6.47M), and Renaissance Technologies LLC ($15.80K). How much institutional buying is happening at Daré Bioscience? Institutional investors have bought a total of 6,485,800 shares in the last 24 months. This purchase volume represents approximately $35.92M in transactions. Which Daré Bioscience major shareholders have been selling company stock? The following institutional investors have sold Daré Bioscience stock in the last 24 months: Geode Capital Management LLC ($917.50K), State Street Corp ($258.70K), Founders Financial Securities LLC ($233.82K), and Virtu Financial LLC ($44.99K). How much institutional selling is happening at Daré Bioscience? Institutional investors have sold a total of 1,455,008 shares in the last 24 months. This volume of shares sold represents approximately $6.70M in transactions. Related Companies Alto Neuroscience Major Shareholders Inventiva Major Shareholders Nuvectis Pharma Major Shareholders DBV Technologies Major Shareholders Protara Therapeutics Major Shareholders Inozyme Pharma Major Shareholders Metagenomi Major Shareholders Elutia Major Shareholders Enanta Pharmaceuticals Major Shareholders IGM Biosciences Major Shareholders This page (NASDAQ:DARE) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe crypto bull market is here, and the stakes couldn’t be higher. The next 3-6 months? They’re the most ex...Crypto Swap Profits | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredA deadly mistake in my prediction…I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Daré Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Daré Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
